Interní Med. 2005; 7(7): 346-348

New aspects of lipids in nutriton

prof. MUDr. Vladimír Bláha CSc
Klinika gerontologická a metabolická, FN Hradec Králové

Isomeric fatty acids have the same number of carbon and hydrogen atoms, but may have distinct metabolic and health effects. Two well-known examples of isomeric fatty acids are cis and trans monounsaturated fatty acids, and conjugated isomers of linoleic acid (CLA). Apart from an unfavorable effect on serum lipoproteins, trans monounsaturated fatty acids from hydrogenated oils may increase plasma markers for a low-grade inflammatory state. From epidemiological studies, however, it is not possible to conclude if effects of ruminant and industrial trans fatty acids on cardiovascular risk are different. In contrast to in-vitro and animal studies, there are no indications that in humans the two most common CLA isomers (cis9,trans11-CLA and trans10,cis12-CLA) affect body composition differently. Longer-term supplementation, however, may slightly decrease body fat mass without apparent effects on plasma markers for glucose and lipid metabolism. Other studies have even reported adverse effects of CLA supplementation on insulin resistance and lipid peroxidation. Thus evidence is increasing that trans monounsaturated fatty acids from hydrogenated oils increase plasma markers of low-grade chronic inflammation. From epidemiological studies, however, it is not clear if effects of ruminant and industrial trans fatty acids on cardiovascular risk are different. Effects of CLA on body composition remain controversial and more research is needed before the widely available CLA supplements should be advocated as an adjunct to control body weight.

Keywords: Key words: body composition, conjugated linoleic acid, glucose metabolism, inflammation, lipid metabolism, trans fatty acids.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bláha V. New aspects of lipids in nutriton. Interní Med. 2005;7(7):346-348.
Download citation

References

  1. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996; 146: 231-240. Go to original source... Go to PubMed...
  2. Ascherio A, Katan MB, Zock PL, et al. Trans fatty acids and coronary heart disease. N Engl J Med 1999; 340: 1994-1998. Go to original source... Go to PubMed...
  3. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79: 969-973. Go to original source... Go to PubMed...
  4. Baylin A, Kabagambe EK, Ascherio A, et al. High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr 2003; 133: 1186-1191. Go to original source... Go to PubMed...
  5. Belury MA, Mahon A, Banni S. The conjugated linoleic acid (CLA) isomer t10,c12-CLA is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr 2003; 133: 257S-260S. Go to original source... Go to PubMed...
  6. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 2002; 22: 505-531. Go to original source... Go to PubMed...
  7. Clifton PM, Keogh JB, Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 2004; 134: 874-879. Go to original source... Go to PubMed...
  8. Cuchel M, Schwab US, Jones PJH, et al. Impact of hydrogenated fat consumption on endogenous cholesterol synthesis and susceptibility of low-density lipoprotein to oxidation in moderately hypercholesterolemic individuals. Metabolism 1996; 45: 241-247. Go to original source... Go to PubMed...
  9. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320-328. Go to original source... Go to PubMed...
  10. Diabetes Prevention Program Research Group. Reduction in body the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-404. Go to original source... Go to PubMed...
  11. Evans ME, Brown JM, McIntosh MK. Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J Nutr Biochem 2002; 13: 508-516. Go to original source... Go to PubMed...
  12. Gaullier J-M, Halse J, H ye K, Kristiansen K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004; 79: 1118-1125. Go to original source... Go to PubMed...
  13. Kamphuis MMJW, Lejeune MPGM, Saris WHM, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003; 27: 840-847. Go to original source... Go to PubMed...
  14. Katan MB, Mensink RP, Zock PL. Trans fatty acids and their effects on lipoproteins in man. Ann Rev Nutr 1995; 15: 473-493. Go to original source... Go to PubMed...
  15. Kraus RM. Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr 2001; 21: 283-295. Go to original source... Go to PubMed...
  16. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003; 44: 2234-2241. Go to original source... Go to PubMed...
  17. Malpuech-Brug?re C, Verboeket-van de Venne WPHG, Mensink RP, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 2004; 12: 591-598. Go to original source... Go to PubMed...
  18. Mauger J-F, Lichtenstein AH, Ausman LM, et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003; 78: 370-375. Go to original source... Go to PubMed...
  19. Mensink RP, Zock PL, Kester A, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol ratio and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155. Go to original source... Go to PubMed...
  20. Mozaffarian D, Pischon T, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004; 79: 606-612. Go to original source... Go to PubMed...
  21. Oomen CM, Ocké MC, Feskens EJM, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen elderly study: a prospective population-based study. Lancet 2001; 357: 746-751. Go to original source... Go to PubMed...
  22. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the alpha-tocopherol, beta-carotene cancer prevention study. Am J Epidemiol 1997; 145: 876-887. Go to original source... Go to PubMed...
  23. Risérus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25: 1516-1521. Go to original source... Go to PubMed...
  24. Risérus U, Vessby B, Ärnlöv J, Basu S. Effects of cis9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004; 80: 279-283. Go to original source... Go to PubMed...
  25. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126. Go to original source... Go to PubMed...
  26. Terpstra AHM. Effect of conjugated linoleic acid on body composition and plasma lipids in human: an overview of the literature. Am J Clin Nutr 2004; 79: 352-361. Go to original source... Go to PubMed...
  27. Tricon S, Burdge GC, Kew S, et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 2004; 80: 614-620. Go to original source... Go to PubMed...
  28. Weggemans RM, Rudrum M, Trautwein EA. Intake of ruminant versus industrial trans fatty acids and risk of coronary heart disease: what is the evidence? Eur J Lipid Sci Technol 2004; 106: 390-397. Go to original source...
  29. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341: 581-585. Go to original source... Go to PubMed...
  30. Wolff RL, Precht D, Molkentin J. Occurrence and distribution profiles of trans-18:1 acids in edible fats of natural origin. In: Sébédio JL, Christie WW, editors. Trans fatty acids in human nutrition. Dundee: The Oily Press; 1998: 1-33.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.